Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2006;108:61-69
© 2006 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dokras, A.
Right arrow Articles by Sparks, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dokras, A.
Right arrow Articles by Sparks, A.
Related Collections
Right arrow Infertility including ART
Right arrow Obstetric complications of pregnancy

ORIGINAL RESEARCH

Obstetric Outcomes After In Vitro Fertilization in Obese and Morbidly Obese Women

Anuja Dokras, MD, PhD, Lindsey Baredziak, Jill Blaine, Craig Syrop, MD, Bradley J. VanVoorhis, MD and Amy Sparks, PhD

From the Department of Obstetrics and Gynecology at the University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa.

OBJECTIVE: In addition to numerous health detriments caused by obesity, fertility and pregnancy success may also be compromised. The aims of this study were to compare the effects of obesity and morbid obesity on in vitro fertilization (IVF) outcomes. We also investigated the effects of obesity on obstetric outcomes after IVF treatment.

METHODS: Retrospective study of women less than 38 years of age during their first fresh IVF cycle (January 1995 to April 2005).

RESULTS: A total of 1,293 women were included in the study, with 236 obese women (body mass index [BMI] = 30–39.9) and 79 morbidly obese women (BMI ≥ 40). The morbidly obese group had a 25.3% IVF cycle cancellation rate compared with 10.9% in normal-weight women (odds ratio 2.73, 95% confidence interval 1.49–5.0), P < .001). Morbidly obese women without polycystic ovarian syndrome had an even higher cancellation rate (33%). Women with higher BMI required significantly more days of gonadotropin stimulation but had lower peak estradiol levels (P < .001). There were no significant differences in clinical pregnancy or delivery rates between the four BMI groups. Of the women who delivered, there was a significant linear trend for risk of preeclampsia, gestational diabetes, and cesarean delivery with increasing BMI (P < .03).

CONCLUSION: We report a significantly higher risk for IVF cycle cancellation in morbidly obese patients with no effect of BMI on clinical pregnancy or delivery rate. However, obese and morbidly obese subjects had a significantly higher risk for obstetric complications. This target population should be aggressively counseled regarding their increased obstetric risk and offered treatment options for weight reduction before the initiation of fertility therapy.

LEVEL OF EVIDENCE: II-2




This article has been cited by other articles:


Home page
Hum ReprodHome page
M. L. Sneed, M. L. Uhler, H. E. Grotjan, J. J. Rapisarda, K. J. Lederer, and A. N. Beltsos
Body mass index: impact on IVF success appears age-related
Hum. Reprod., May 24, 2008; (2008) den188v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Obstetricians and Gynecologists.